With an eye on treatment
we are dedicated to addressing patient needs with lasting impact.
DEXYCU is approved for the treatment of inflammation following ocular surgery.
Highlights:
By 2030, ~6 million cataract surgeries a year will be performed in the US
We created simplified treatment
Cataract surgeries will continue to grow as the population ages.
LICENSE AGREEMENTS
Rights for China, Hong Kong, Taiwan, Macau , Korea, and certain SE Asia countries licensed to Ocumension with a royalty on sales payable to EyePoint.
DEXYCU® (dexamethasone intraocular suspension) 9% is indicated for the treatment of postoperative inflammation.
None.
Increase in Intraocular Pressure
Delayed Healing
Exacerbation of Infection
Cataract Progression
Please click here for full Prescribing Information.
EyePoint and the EyePoint logo are registered trademarks of EyePoint Pharmaceuticals, Inc.
©2018-2022 EyePoint Pharmaceuticals, Inc. All Rights Reserved.
EyePoint and the EyePoint logo are registered trademarks of EyePoint Pharmaceuticals, Inc. With an Eye on Patients is a trademark of EyePoint Pharmaceuticals, Inc.
©2018-2022 EyePoint Pharmaceuticals, Inc. All Rights Reserved.
EyePoint, the EyePoint logo, and Delivering Innovation to the Eye are registered trademarks of EyePoint Pharmaceuticals, Inc.
©2018-2022 EyePoint Pharmaceuticals, Inc. All Rights Reserved.
EyePoint, the EyePoint logo, Durasert, and DEXYCU are registered trademarks of EyePoint Pharmaceuticals, Inc. Verisome is a registered trademark of Ramscor, Inc. All other trademarks are the property of their respective owners.
©2018-2022 EyePoint Pharmaceuticals, Inc. All Rights Reserved.
EyePoint, the EyePoint logo, and Durasert are registered trademarks of EyePoint Pharmaceuticals, Inc.
©2018-2022 EyePoint Pharmaceuticals, Inc. All Rights Reserved.
EyePoint, the EyePoint logo, and the DEXYCU logo are registered trademarks of EyePoint Pharmaceuticals, Inc.
©2018-2022 EyePoint Pharmaceuticals, Inc. All Rights Reserved.
EyePoint, the EyePoint logo, and Durasert are registered trademarks of EyePoint Pharmaceuticals, Inc.
©2018-2022 EyePoint Pharmaceuticals, Inc. All Rights Reserved.
EyePoint, the EyePoint logo, DEXYCU, and the DEXYCU logo are registered trademarks of EyePoint Pharmaceuticals, Inc.
©2018-2022 EyePoint Pharmaceuticals, Inc. All Rights Reserved.
EyePoint, the EyePoint logo, Durasert, and DEXYCU are registered trademarks of EyePoint Pharmaceuticals, Inc.
©2018-2022 EyePoint Pharmaceuticals, Inc. All Rights Reserved.
EyePoint, the EyePoint logo, and DEXYCU are registered trademarks of EyePoint Pharmaceuticals, Inc.
©2018-2022 EyePoint Pharmaceuticals, Inc. All Rights Reserved.